Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

778.90INR
20 Nov 2018
Change (% chg)

Rs-15.10 (-1.90%)
Prev Close
Rs794.00
Open
Rs791.00
Day's High
Rs792.65
Day's Low
Rs777.00
Volume
1,213,467
Avg. Vol
3,612,092
52-wk High
Rs827.45
52-wk Low
Rs527.00

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma Gets U.S. FDA Approval To Make Azithromycin Tablets 250 Mg And 500 Mg
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Aurobindo Pharma Ltd ::GETS FINAL APPROVAL FROM USFDA TO MANUFACTURE AZITHROMYCIN TABLETS 250 MG AND 500 MG.DRUG INDICATED FOR TREATMENT OF PATIENTS WITH MILD TO MODERATE INFECTIONS .  Full Article

Aurobindo Pharma Gets USFDA Nod For Ibuprofen OTC Capsules
Monday, 2 Jul 2018 

July 2 (Reuters) - Aurobindo Pharma Ltd ::SAYS RECEIVED USFDA APPROVAL FOR IBUPROFEN OTC CAPSULES.CO'S IBUPROFEN CAPSULES ARE GENERIC EQUIVALENT OF PFIZER’S ADVIL LIQUI-GELS CAPSULES; PRODUCT WILL BE LAUNCHED IN SEP 2018.IBUPROFEN IS USED TO RELIEVE PAIN FROM VARIOUS CONDITIONS SUCH AS HEADACHE, DENTAL PAIN, MUSCULAR ACHES.  Full Article

Aurobindo Pharma Gets U.S. FDA Nod For Ertapenem Injection
Tuesday, 26 Jun 2018 

June 26 (Reuters) - Aurobindo Pharma Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR ERTAPENEM INJECTION.SAYS PRODUCT WILL BE LAUNCHED IN JULY 2018.  Full Article

Aurobindo Pharma Gets U.S. FDA Approval For Fondaparinux Sodium Injection
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - Aurobindo Pharma Ltd ::SAYS GETS U.S. FDA APPROVAL FOR FONDAPARINUX SODIUM INJECTION.  Full Article

Aurobindo Pharma gets U.S. FDA nod for esomeprazole magnesium DR capsules OTC
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Aurobindo Pharma Ltd :Says ‍received final approval from U.S. FDA to manufacture esomeprazole magnesium delayed-release capsules OTC, 20mg​.Says ‍product will be launched immediately​.  Full Article

Aurobindo Pharma gets USFDA approval for drugs used for treatement of HIV-1 infection
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Aurobindo Pharma Ltd :Receives USFDA tentative approval for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets.Drugs used for treatement of HIV-1 infection along as a regimen in adults and pediatric patients weighing over 40 kgs.  Full Article

Aurobindo Pharma second-quarter profit falls nearly 22 percent

Aurobindo Pharma Ltd, India's second-largest drugmaker by market capitalisation, posted a 21.7 percent fall in its second-quarter profit on Monday, hurt by higher expenses, but beat analysts' estimates.